TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in cognitive function as measured by SCAG Factor 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical global assessment of tolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Change in E/e' over 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of pockets and clinical attachment gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total counts of bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Small intestine permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postprandial C-peptide index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of reoperation for nonunion
Endpoint domain: Adverse events/effects
Primary endpoint: Time to reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Late diastolic LV filling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Onset of action (decrease of Raw)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Morning FEV(1) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fissure healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of headaches
Endpoint domain: Adverse events/effects
Primary endpoint: Development of Surgical Site Infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Response to treatment
Endpoint domain: Physiological/clinical
Primary endpoint: Depressive episodes
Endpoint domain: Physiological/clinical
Primary endpoint: Median marginal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of peri-implant mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Biofilm colonization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of retina affected by CMV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs of ocular inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SFR during MP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TTFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: event-free survival at 4 years
Endpoint domain: Mortality/survival
Primary endpoint: cumulative incidence of CNS relapse at 4 years
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of SREs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fasting plasma glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycosylated hemoglobin A1(c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting serum High-density lipoprotein (HDL)-cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gait and balance dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving target platelet count ≥ 50 × 10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sensory block duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for postoperative morphine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean fall in office systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Four-year disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Annual rate of contralateral breast cancers (CLBC)
Endpoint domain: Mortality/survival
Primary endpoint: Appropriateness of PAC use in patients with severe ventricular impairment and unstable angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median duration of relief after first procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD4 counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of high-level resistance to zidovudine
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery time from exertion-induced breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lateral e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: septal e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: left ventricular area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cumulative percentage dose recovery (cPDR) at 6 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ulcer reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average reduction in annual cost per successfully treated patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: adenoma recurrence risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: risk for advanced lesions or multiple adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Arterial Pressure (MAP) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate (HR) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postcaesarean sanguineous loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Loss of hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Loss of hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinically significant adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of studied words correctly recognized
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of Remember responses associated with true recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of H. pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sweating-to-vasoconstriction range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vasoconstriction-to-shivering range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sweating-to-shivering range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rate of desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wound complication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: median cosmetic scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: scar color
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: State and trait anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived stressors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diastolic blood pressure index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in fasting triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ex vivo susceptibility of LDL to oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual analogue scale anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dynamic gait index test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in overall RQLQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in total symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in NPIF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma drug concentration versus time curve (AUC)0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma drug concentration versus time curve (AUC)0-inf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percentage of heartburn-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Woodcock‐Johnson Tests of Achievement in math
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YRBSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPVT‐III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Woodcock‐Johnson Tests of Achievement in reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortico-spinal excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive impairment improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: muscle perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal glucose infusion rate (GIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to maximal GIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the GIR curve (GIR(AUC))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reported tick bite within the previous year
Endpoint domain: Adverse events/effects
Primary endpoint: psychological outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Percentage change from baseline in PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lipid oxidative efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complex V protein content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle ceramide content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reported confidence in driving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported impairment during simulated driving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collisions during simulated driving
Endpoint domain: Adverse events/effects
Primary endpoint: Volumetric measurements reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB incidence
Endpoint domain: Mortality/survival
Primary endpoint: Maternal death
Endpoint domain: Mortality/survival
Primary endpoint: Infant death
Endpoint domain: Mortality/survival
Primary endpoint: Pain score at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid requirement at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically important drug‐associated electrolyte disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite end point of death, myocardial infarction, or target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Quality-adjusted year gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depression-free day
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incremental direct cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: anesthesia onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anesthesia related times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dyskinesia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exertion after walking (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-free interval
Endpoint domain: Mortality/survival
Primary endpoint: Analgesic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary dysmenorrhea symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-RM strength of lower body
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body mass and BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak postocclusive reactive hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: GIT function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in OA symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cause-specific survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in spherical equivalent manifest refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival of the native hip
Endpoint domain: Mortality/survival
Primary endpoint: Need for total hip replacement (THR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in behavior of screening practice
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Wound healing time for superficial partial-thickness burn wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing rate on 7 post-burn day for superficial partial-thickness burn wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing time for deep-partial thickness burn wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing rate on 20 post-burn day for deep-partial thickness burn wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esthetic perception of teeth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NPI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAS-cog score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carotid IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Grade 3 and 4 acute toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: abnormal free water handling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: fetal death
Endpoint domain: Adverse events/effects
Primary endpoint: low birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Nonrecurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periodontal ligament widening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter-radicular radiolucency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average number of daily toilet voids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: average volume per void
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean reduction in Maximum Pain Intensity at Rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of oral symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients reporting ≥1 CV TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of CV-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in BP, pulse, and QT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: T-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Demethylation of FOXP3 CpG sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of the single-item question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the single-item question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value of the single-item question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cfDNA levels correlation with metastases and survival
Endpoint domain: Mortality/survival
Primary endpoint: cfDNA kinetic as a biomarker to monitor therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapist competence/adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working alliance rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute change in daily 'off' time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peroneus longus reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean onset time of pulpal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-peptide secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cutaneous contribution to vasoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cutaneous contribution to shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-ATM weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Z-score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal fat excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Correction of medication discrepancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active patient communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Facilitative clinician communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative stroke rate
Endpoint domain: Mortality/survival
Primary endpoint: Secondary hydrocele formation
Endpoint domain: Adverse events/effects
Primary endpoint: Varicocele recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Pregnancy rate during follow-up
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of preterm delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Prevention of malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of immune function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Alleviation of adverse effects of chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first disappearance of oral ulcers and vesicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time of fever clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of feces and moving gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success rate of 3D‐GR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrafraction prostate motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: nighttime sleep latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lapses of attention frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed and distance traveled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency of propulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVNA titers ≥0.5 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of colorectal discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes